Inhibition of cardiac PERK signaling promotes peripartum cardiac dysfunction
Abstract Peripartum cardiomyopathy (PPCM) is a life-threatening heart failure occurring in the peripartum period. Although mal-angiogenesis, induced by the 16-kDa N-terminal prolactin fragment (16 K PRL), is involved in the pathogenesis, the effect of full-length prolactin (23 K PRL) is poorly under...
Guardado en:
Autores principales: | Takashi Shimizu, Akashi Taguchi, Yoshiki Higashijima, Yasuharu Kanki, Ryo Nakaki, Yoshihiro Urade, Youichiro Wada |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/bd475300e3704da38011878cdf321845 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Author Correction: PERK participates in cardiac valve development via fatty acid oxidation and endocardial-mesenchymal transformation
por: Takashi Shimizu, et al.
Publicado: (2021) -
Peripartum cardiomyopathy and cardiac resynchronization therapy: Case reports and literature review
por: Norman C. Wang, MD, MS, FHRS, et al.
Publicado: (2021) -
Thbs1 induces lethal cardiac atrophy through PERK-ATF4 regulated autophagy
por: Davy Vanhoutte, et al.
Publicado: (2021) -
NOD1 activation induces cardiac dysfunction and modulates cardiac fibrosis and cardiomyocyte apoptosis.
por: María Fernández-Velasco, et al.
Publicado: (2012) -
Characterization of aging-associated cardiac diastolic dysfunction.
por: Wei-Ting Chang, et al.
Publicado: (2014)